ORAL FORMULATION FOR DEXLANSOPRAZOLE
- 专利权人:
- Zhiqun Shen;MIn Michael He;Enjun Fu;Yu Zhang;Fang-yu Liu
- 发明人:
- Zhiqun Shen,Yu Zhang,Enjun Fu,MIn Michael He,Fang-yu Liu
- 申请号：
- US13510924
- 公开号：
- US20130273171A1
- 申请日:
- 2010.11.18
- 申请国别(地区):
- US
- 年份:
- 2013
- 代理人:
- 摘要：
- A stable formulation of dexlansoprazole for treating a digestive disorder, and methods of manufacturing the same.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Oral formulation for dexlansoprazole
- Use of an angiotensin ii receptor antagonist for the production of a pharmaceutical composition for the prevention or treatment of vascular diseases or metabolic disorders and / or systemic disease in cats.
- COMPOSITION WITH GROWTH FACTORS, TO BE USED IN THE INTRANASAL TREATMENT OF A NEURODEGENERATIVE DISEASE OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM, AND ITS METHOD OF MANUFACTURE
- COMPOSITION WITH GROWTH FACTORS, TO BE USED IN THE INTRANASAL TREATMENT OF A NEURODEGENERATIVE DISEASE OR OTHER DISEASES OF THE CENTRAL NERVOUS SYSTEM, AND ITS METHOD OF MANUFACTURE
- 2,4-di(phenylamino)-pyrimidines useful in the treatment of neoplastic diseases, inflammatory and immune system disorders
